Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Martha Massaro-Corredor
ResearcherPublications, citations & collaboration network
Martha Massaro-Corredor is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 8 works, 99 citations, an h-index of 6 and an i10-index of 4.
8
Works
99
Citations
6
h-index
4
i10-index
IDs:OpenAlex
How has Martha Massaro-Corredor's publication output changed over time?
ScholarIQpublication output · 2020–2024
Output declined50% over the shown period — from 2 works in 2020 to 1 in 2024.
2
4
1
1
2020202120222024
What are the most-cited papers on Martha Massaro-Corredor?
ScholarIQmost cited works
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial
Roberto González-Salinas, Paul Karpecki, Elizabeth Yeu, Mark Holdbrook, Stephanie N. Baba, Juan Carlos Ceballos, Martha Massaro-Corredor, Claudia Corredor-Ortega, Nallely Ramos-Betancourt, Hugo Quiroz–Mercado
S137552098. 202132 CitationsOPEN ACCESS
Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of <i>Demodex</i> Blepharitis: A Pilot Study
Roberto González-Salinas, Elizabeth Yeu, Mark Holdbrook, Stephanie N. Baba, Juan Carlos Ceballos, Martha Massaro-Corredor, Claudia Corredor-Ortega, Nallely Ramos-Betancourt, Hugo Quiroz–Mercado
Journal of Ophthalmology. 202122 CitationsOPEN ACCESS
Collarette Elimination and <i>Demodex</i> Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25%
Roberto González-Salinas, Elizabeth Yeu, Mark Holdbrook, Stephanie N. Baba, Juan Carlos Ceballos, Martha Massaro-Corredor, Claudia Corredor-Ortega, Nallely Ramos-Betancourt, Hugo Quiroz–Mercado
Journal of Ocular Pharmacology and Therapeutics. 202117 CitationsOPEN ACCESS
Treatment of <i>Demodex</i> Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle
Elizabeth Yeu, Mark Holdbrook, Stephanie N. Baba, Juan Carlos Ceballos, Martha Massaro-Corredor, Claudia Corredor-Ortega, Nallely Ramos-Betancourt, Hugo Quiroz–Mercado, Roberto González-Salinas
Ocular Immunology and Inflammation. 202212 CitationsOPEN ACCESS
Long-term refractive outcomes in patients with cataracts and keratoconus after phacoemulsification with toric intraocular lens implant
Erika Fernández-Muñoz, Jorge Blanco-Gómez, Rafael Vázquez-Rojas, Katia Camargo-Ibarias, Martha Massaro-Corredor, Roberto González-Salinas
European Journal of Ophthalmology. 20206 Citations
Related on ScholarIQ
Asociacion Para Evitar la Ceguera en México Hospital Dr. Luis Sánchez Bulnes
Institution
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial
Paper
Safety and Efficacy of Topical Lotilaner Ophthalmic Solution 0.25% for the Treatment of <i>Demodex</i> Blepharitis: A Pilot Study
Paper
Collarette Elimination and <i>Demodex</i> Mite Eradication with Topical Lotilaner Ophthalmic Solution, 0.25%
Paper
Treatment of <i>Demodex</i> Blepharitis: A Prospective, Randomized, Controlled, Double-Masked Clinical Trial Comparing Topical Lotilaner Ophthalmic Solution, 0.25% Eyedrops to Vehicle
Paper
Long-term refractive outcomes in patients with cataracts and keratoconus after phacoemulsification with toric intraocular lens implant
Paper